4.4 Article

Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion

Journal

INFECTION GENETICS AND EVOLUTION
Volume 28, Issue -, Pages 635-647

Publisher

ELSEVIER
DOI: 10.1016/j.meegid.2014.05.025

Keywords

Malaria; Anopheles; Transmission-blocking; Plasmodium vivax; Plasmodium falciparum; Midgut

Funding

  1. National Institutes of Health - United States (NIH) [K22AI077707, R01AI082587, T32]
  2. NIH National Center for Research Resources [UL1 RR025005]
  3. Bloomberg Family Foundation
  4. Johns Hopkins Malaria Research Institute (JHMRI)
  5. JHMRI Pre-doctoral Fellowship
  6. Calvin A. and Helen L. Lang postdoctoral fellowship
  7. Swiss National Science Foundation [PBZHP3_141430]
  8. Swiss National Science Foundation (SNF) [PBZHP3_141430] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Novel strategies to directly thwart malaria transmission are needed to maintain the gains achieved by current control measures. Transmission-blocking interventions (TBIs), namely vaccines and drugs targeting parasite or mosquito molecules required for vector-stage parasite development, have been recognized as promising approaches for preventing malaria transmission. However, the number of TBI targets is limited and their degree of conservation among the major vector-parasite systems causing human disease is unclear. Therefore, discovery and characterization of novel proteins involved in vector-stage parasite development of Plasmodium falciparum and Plasmodium vivax is paramount. We mined the recent Anopheles gambiae midgut lipid raft proteome for putative mosquito-derived TBI targets and characterized a secreted glycoconjugate of (u) under bar nknown function, AgSGU. We analyzed molecular variation in this protein among a range of anopheline mosquitoes, determined its transcriptomic and proteomic profiles, and conducted both standard and direct membrane feeding assays with P. falciparum (lab/field) and P. vivax (field) in An. gambiae and Anopheles dirus. We observed that alpha-AgSGU antibodies significantly reduced midgut infection intensity for both lab and field isolates of P. falciparum in An. gambiae and An. dirus. However, no transmission-reducing effects were noted when comparable concentrations of antibodies were included in P. vivax-infected blood meals. Although antibodies against AgSGU exhibit transmission-reducing activity, the high antibody titer required for achieving 80% reduction in oocyst intensity precludes its consideration as a malaria mosquito-based TBI candidate. However, our results suggest that P. falciparum and P. vivax ookinetes use a different repertoire of midgut surface glycoproteins for invasion and that alpha-AgSGU antibodies, as well as antibodies to other mosquito-midgut microvillar surface proteins, may prove useful as tools for interrogating Plasmodium-mosquito interactions. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available